![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 30 April 2024
Sec. Skin Cancer
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1418213
This article is a correction to:
Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration
A Corrigendum on:
Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration
By Degan S, May BL, Jin YJ, Hammouda MB, Sun H, Zhang G, Wang Y, Erdmann D, Warren W and Zhang JY (2022). Front. Oncol. 12:782877. doi: 10.3389/fonc.2022.782877
In the published article, an author name was incorrectly written as Manel Ben Hammoda.
The correct spelling is Manel Ben Hammouda.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: MEK; melanoma, autophagy, chloroquine, MEK, tremetinib, immune cell infiltration
Citation: Degan S, May BL, Jin YJ, Ben Hammouda M, Sun H, Zhang G, Wang Y, Erdmann D, Warren W and Zhang JY (2024) Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration. Front. Oncol. 14:1418213. doi: 10.3389/fonc.2024.1418213
Received: 16 April 2024; Accepted: 17 April 2024;
Published: 30 April 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Degan, May, Jin, Ben Hammouda, Sun, Zhang, Wang, Erdmann, Warren and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jennifer Y. Zhang, SmVubmlmZXIuemhhbmdAZHVrZS5lZHU=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.